HIV-1 Envelope Variants and Their Role in Disease Progression
Author Information
Author(s): Jasminka Sterjovski, Melissa J Churchill, Anne Ellett, Lachlan R Gray, Michael J Roche, Rebecca L Dunfee, Damian FJ Purcell, Nitin Saksena, Bin Wang, Secondo Sonza, Steven L Wesselingh, Ingrid Karlsson, Eva-Maria Fenyo, Dana Gabuzda, Anthony L Cunningham, Paul R Gorry
Primary Institution: Macfarlane Burnet Institute for Medical Research & Public Health, Melbourne, Victoria, Australia
Hypothesis
The study investigates the role of Asn 362 in enhancing the fusogenicity of CCR5-restricted HIV-1 envelope glycoprotein variants from AIDS patients.
Conclusion
The presence of Asn 362 in HIV-1 envelope variants is associated with enhanced fusogenicity and may contribute to CD4+ T-cell loss in AIDS patients.
Supporting Evidence
- A-R5 Envs had enhanced fusogenicity compared to PA-R5 Envs.
- N362 was associated with faster entry kinetics of HIV-1.
- A-R5 Envs showed reduced sensitivity to the fusion inhibitor T-20.
- Mutagenesis studies confirmed N362's role in enhancing fusogenicity.
- Structural models suggest N362 stabilizes the CD4-bound Env structure.
- Presence of N362 correlated with increased sensitivity to neutralization by specific antibodies.
- Enhanced fusogenicity may contribute to CD4+ T-cell loss in AIDS patients.
Takeaway
Some HIV-1 viruses can fuse better with human cells, which might help them make people sick faster. A specific part of the virus, called Asn 362, helps it do this.
Methodology
The study characterized 37 full-length R5 Envs from HIV-1 variants isolated from patients, using quantitative cell-cell fusion assays and sequence analysis.
Potential Biases
Potential bias in sample selection from specific patient populations.
Limitations
The study may not account for all genetic variations in HIV-1 and their effects on fusogenicity.
Participant Demographics
Patients with asymptomatic HIV-1 infection and AIDS.
Statistical Information
P-Value
0.0004
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website